Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS INC | $7.35 | $4.41 | 66.83% | 122.50x | -22.52x | 5.63x | 6.72x | 0.63x | -$150.00k | -0.03% | $106.03M | 1.19 | $676.55M | 52.69 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.78 | $41.01 | 28.69% | 131.95x | 13.30x | 14.09x | 6.05x | 0.47x | $46.73M | 1.74% | $450.12M | 8.86 | $2.71B | 93.38 | ||
| ADMA | ADMA BIOLOGICS INC | $10.60 | $11.56 | -8.34% | 17.10x | 10.88x | 4.95x | 5.29x | 0.45x | $27.82M | 1.10% | $477.32M | 2.00 | $2.51B | 12.69 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $301.19 | $79.15 | 280.51% | 126.02x | 44.13x | 10.62x | 50.62x | 1.59x | $465.38M | 1.18% | $789.18M | 6.02 | $41.26B | 65.34 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.67 | $18.54 | -47.84% | 6.91x | 19.50x | 5.02x | 3.67x | 0.31x | -$1.99M | -0.37% | $154.66M | 2.80 | $568.54M | 5.72 | ||
| CORT | CORCEPT THERAPEUTICS INC | $46.59 | $20.54 | 126.87% | 49.04x | 85.86x | 6.36x | 7.65x | 1.06x | $141.79M | 2.93% | $647.81M | 6.24 | $4.84B | 107.10 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.06 | $69.81 | -9.66% | 23.89x | 7.71x | 5.41x | 152.46x | 0.40x | $644.59M | 8.53% | $48.81M | 0.41 | $9.45B | 16.49 | ||
| KRYS | KRYSTAL BIOTECH INC | $259.95 | $108.01 | 140.68% | 36.72x | 33.39x | 19.34x | 6.23x | 1.31x | $189.35M | 2.52% | $1.22B | 42.14 | $7.11B | 36.28 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.76 | $3.33 | 42.95% | 21.64x | 17.12x | 2.91x | 4.98x | 0.78x | $13.21M | 3.51% | $76.53M | 0.97 | $319.21M | 16.25 | ||
| RPRX | ROYALTY PHARMA PLC | $49.49 | $41.47 | 19.34% | 27.65x | 9.58x | 8.94x | 2.94x | 0.55x | $2.22B | 10.43% | $9.71B | 22.60 | $36.88B | 34.19 | ||
| VCEL | VERICEL CORP | $33.43 | $8.41 | 297.50% | 101.30x | 75.77x | 6.09x | 4.79x | 1.77x | $24.75M | 1.47% | $354.64M | 7.05 | $1.69B | 48.51 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.05 | $35.90 | -13.51% | 11.25x | 8.46x | 2.06x | 2.06x | 0.52x | $347.89M | 19.49% | $870.22M | 15.14 | $1.21B | 4.73 | ||
| MNKD | MANNKIND CORP | $2.75 | $1.07 | 158.02% | 137.50x | 316.09x | 2.41x | -16.61x | 1.00x | $13.69M | 1.64% | -$51.02M | -0.17 | $1.38B | 26.02 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.95 | $5.03 | 713.49% | 227.50x | -34.71x | 5.15x | 14.14x | 3.53x | $45.01M | 0.87% | $370.15M | 2.93 | $5.24B | 74.88 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $52.99 | $16.52 | 220.69% | 54.07x | 48.04x | 5.38x | 6.73x | 1.66x | $164.23M | 4.05% | $605.69M | 7.92 | $3.90B | 34.95 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.21 | $46.85 | 15.70% | 29.79x | 12.40x | 3.23x | 1.71x | 0.51x | $724.96M | 6.97% | $6.09B | 31.74 | $9.71B | 16.95 | ||
| EXEL | EXELIXIS INC | $44.69 | $35.08 | 27.40% | 15.52x | 13.98x | 5.23x | 5.37x | 0.81x | $875.84M | 7.22% | $2.16B | 7.96 | $11.30B | 11.36 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $224.86 | $108.95 | 106.38% | 34.92x | 23.46x | 16.22x | 4.41x | 1.07x | $48.09M | 1.11% | $1.02B | 52.60 | $4.76B | 23.88 | ||
| TECH | BIO-TECHNE CORP | $51.95 | $15.47 | 235.84% | 99.90x | 25.68x | 6.66x | 4.04x | 1.44x | $223.02M | 2.75% | $2.01B | 12.90 | $8.31B | 36.68 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $686.36 | $439.56 | 56.15% | 16.13x | 14.64x | 4.78x | 2.29x | 1.16x | $4.11B | 5.76% | $31.42B | 302.15 | $71.70B | 12.48 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $423.24 | $185.69 | 127.92% | 27.38x | 21.73x | 9.02x | 5.76x | 1.46x | $3.19B | 2.95% | $18.67B | 73.00 | $104.28B | 21.43 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $28.26 | $14.80 | 90.91% | 16.15x | 14.74x | 5.87x | 3.62x | 1.89x | $208.61M | 6.04% | $954.27M | 7.80 | $2.74B | 8.53 | ||
| VCYT | VERACYTE INC | $31.78 | $10.21 | 211.26% | 37.83x | 29.98x | 4.83x | 1.93x | 1.98x | $126.63M | 5.07% | $1.31B | 16.67 | $2.20B | 23.76 | ||
| UTHR | UNITED THERAPEUTICS CORP | $571.07 | $266.27 | 114.47% | 18.95x | 19.54x | 7.95x | 3.53x | 1.97x | $1.04B | 4.11% | $7.10B | 160.19 | $23.47B | 12.90 | ||
| XOMA | XOMA ROYALTY CORP | $40.99 | $9.95 | 311.91% | 26.79x | 83.72x | 9.50x | 5.81x | 9.11x | -$1.83M | -0.37% | $83.94M | 6.95 | $531.22M | 15.32 | ||
| INCY | INCYTE CORP | $99.10 | $65.15 | 52.11% | 13.59x | 12.80x | 3.68x | 3.52x | 1.37x | $1.45B | 7.34% | $5.62B | 28.21 | $16.37B | 8.75 | ||
| MDXG | MIMEDX GROUP INC | $3.09 | $1.87 | 65.23% | 9.35x | 27.50x | 1.09x | 1.79x | 18.09x | $72.97M | 16.01% | $256.55M | 1.74 | $310.17M | 3.90 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.48 | $3.89 | 92.52% | 12.06x | 18.33x | 1.64x | 2.92x | 5.34x | $41.73M | 11.15% | $130.34M | 2.61 | $377.38M | 7.07 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.